|
Jan 16
|
Should Value Investors Buy DaVita (DVA) Stock?
|
|
Jan 16
|
Here's Why You Should Retain Masimo (MASI) Stock for Now
|
|
Jan 15
|
IDEXX (IDXX) Enhances Fecal Dx Antigen Testing Platform
|
|
Jan 15
|
Integer Holdings (ITGR) Hits 52-Week High: What's Driving It?
|
|
Jan 15
|
Veeva Systems (VEEV) Offerings Adopted by SK Life Science
|
|
Jan 15
|
Best Growth Stocks to Buy for January 15th
|
|
Jan 15
|
Beat the Market the Zacks Way: DaVita, Block, Home Depot in Focus
|
|
Jan 15
|
Quest Diagnostics (DGX) Inks New Deal With Ultima Genomics
|
|
Jan 12
|
Don't Overlook These Top Value Stocks in January It's Time to Buy
|
|
Jan 12
|
Here's Why You Should Retain Charles River (CRL) Stock Now
|
|
Jan 12
|
Inari (NARI) Preliminary Q4 Revenues Ride on Procedure Demand
|
|
Jan 12
|
Masimo (MASI) Posts Preliminary Q4 Results, Issues FY24 View
|
|
Jan 12
|
QIAGEN (QGEN) Wins FDA Clearance for NeuMoDx CT/NG Assay
|
|
Jan 11
|
Glaukos' (GKOS) Preliminary Q4 Revenues Ride on Product Demand
|
|
Jan 11
|
LabCorp (LH) to Expand Clinical Trails Access With New Pact
|
|
Jan 11
|
Integer Holdings (ITGR) Reports Solid Preliminary Q4 Revenues
|
|
Jan 11
|
The Zacks Analyst Blog Highlights DaVita, monday.com, GitLab, Light & Wonder and Sarepta Therapeutics
|
|
Jan 11
|
Medtronic's (MDT) Percept RC DBS System Secures FDA Approval
|